Which β-blocker for heart failure?

American Heart Journal

Volumn 141, Issue 6, 2001, Pages 884-888

  Adams K F , Jr ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

BETA ADRENERGIC RECEPTOR BLOCKING; DRUG EFFECT; DRUG RESEARCH; EDITORIAL; HEART EJECTION FRACTION; HEART FAILURE; HUMAN; PRIORITY JOURNAL;

EID: 0034998769     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2001.115583     Document Type: Article

References (47)

1. MR. Bristow Beta adrenergic receptor blockade in chronic heart failure Circulation 101 2000 558 569
2. HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction—pharmacological approaches J Cardiac Failure 5 1999 357 382
3. MERIT-HF Study Group Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF) Lancet 353 1999 2001 2007
4. M Packer MR Bristow JN Cohn The effect of carvedilol on morbidity and mortality in patients with chronic heart failure N Engl J Med 334 1996 1349 1355
5. CIBIS Investigators and Committees The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomized trial of beta-blockade in heart failure Lancet 353 1999 9 13
6. MR Bristow What type of β-blocker should be used to treat chronic heart failure? Circulation 102 2000 484 486
7. SF Assmann SJ Pocock LE Enos Subgroup analysis and other (mis)uses of baseline data in clinical trials Lancet 355 2000 1064 1069
8. KF. Adams Post hoc subgroup analysis and the truth of a clinical trial [editorial] Am Heart J 136 1998 751 758
9. G Davey Smith M. Egger Meta-analysis: unresolved issues and future developments BMJ 316 1998 221 225
10. J LeLorier G Gregoire A Benhaddad Discrepancies between meta-analyses and subsequent large randomized, controlled trials N Engl J Med 337 1997 536 542
11. M Metra R Giubbini S Nodari Differential effects of beta-blocker in patients with heart failure: a prospective, randomized, double-blind comparison of the long-term effects of metoprolol versus carvedilol Circulation 102 2000 546 551
12. RESOLVD Investigators Effects of metroprolol CR in patients with ischemic and dilated cardiomyopathy: the Randomized Evaluation of Strategies for Left Ventricular Dysfunction pilot study Circulation 101 2000 378 384
13. B Pitt PA Poole-Wilson R Segal Effects of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomized trial. The losartan heart failure survival study ELITE II Lancet 355 2000 1568 1579
14. JN. Cohn Proceedings of the the 73rd annual meeting of the American Heart Association 2000 Nov 15 The Association New Orleans, La. New Orleans 2000
15. A DiLendra G Sabbadini L Salvatore Long-term effects of carvedilol in idiopathic dilated cardiomyopathy with persistent left ventricular dysfunction despite chronic metoprolol J Am Coll Cardiol 33 1999 1926 1934
16. P Lechat S Escolano JL Golmard Prognostic value of bisoprolol-induced hemodynamic effects in heart failure during the Cardiac Insufficiency Bisoprolol study (CIBIS) Circulation 96 1997 2197 2205
17. JK. Kjekshus Importance of heart rate in determining beta-blocker efficacy in acute and long-term acute myocardial infarction intervention trials Am J Cardiol 57 1986 43F 49F
18. NR Alpert LA. Mulieri Human heart failure: determinants of ventricular dysfunction Adv Exp Med Biol 430 1997 97 108
19. EM Gilbert WT Abraham S Olsen Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart Circulation 94 1996 2817 2825
20. J Narula N Haider R Virmani Apoptosis in myocytes in end-stage heart failure N Engl J Med 335 1996 1182 1189
21. G Olivetti R Abbi F Quaini Apoptosis in the failing human heart N Engl J Med 336 1997 1131 1141
22. C Communnal K Singh DR Pimentel Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the β-adrenergic pathway Circulation 98 1998 1329 1334
23. C Communal K Singh DB Sawyer Opposing effects of beta-1 and beta-2 adrenergic receptors on cardiac myocyte apoptosis: role of a pertussis toxin-sensitive G protein Circulation 100 1999 2210 2212
24. T Yoshikawa JD Port K Asanoo Cardiac adrenergic receptor effects of carvedilol Eur Heart J 17 1996 8 16
25. G Iaccarino ED Tomhave RJ Lefkowitz Reciprocal in vivo regulation of myocardial G protein–coupled receptor kinase expression by β-adrenergic receptor stimulation and blockade Circulation 98 1998 1783 1789
26. M Bohm HJ Deutsch D Hartmann Improvement of postreceptor events by metoprolol treatment in patients with chronic heart failure J Am Coll Cardiol 30 1997 992 996
27. RJ Lefkowitz HA Rockman WJ. Koch Catecholamines, cardiac beta-adrenergic receptors, and heart failure Circulation 101 2000 1634 1637
28. Digitalis Investigation Group The effect of digoxin on mortality and morbidity in patients with heart failure N Engl J Med 336 1997 525 533
29. M Packer JR Carver RJ Rodeheffer Effects of oral milrinone on mortality in severe chronic heart failure: the PROMISE Study Research Group N Engl J Med 325 1991 1468 1475
30. G Cintron G Johnson G Francis Prognostic significance of serial changes in left ventricular ejection fraction in patients with congestive heart failure Circulation 87 Suppl 1993 VI17 VI23
31. M. Packer Beta-adrenergic blockade in chronic heart failure: principles, progress, and practice Prog Cardiovasc Dis 41 1998 39 52
32. S Engelhardt L Hein F Wiesmann Progressive hypertrophy and heart failure in beta-1 adrenergic receptor transgenic mice Proc Natl Acad Sci U S A 96 1999 7059 7064
33. JD Bisognano HD Weinberger TJ Bohlmeyer Myocardial-directed overexpression of the human beta-1 adrenergic receptor in transgenic mice J Mol Cell Cardiol 32 2000 817 830
34. SB Liggett NM Tepe JN Lorenz Early and delayed consequences of beta-2 adrenergic receptor overexpression in mouse hearts: critical role for expression level Circulation 101 2000 1707 1714
35. GW Dorn NM Tepe JN Lorenz Low- and high-level transgenic expression of beta-2 adrenergic receptors differentially affect cardiac hypertrophy and function in G αq-overexpressing mice Proc Natl Acad Sci U S A 96 1999 6400 6405
36. HA Rockman KR Chien D Choi Expressions of a beta-adrenergic receptor kinase-1 inhibitor prevents the development of myocardial failure in gene-targeted mice Proc Natl Acad Sci U S A 95 1998 7000 7005
37. S Arber JJ Hunter Ross Jr MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure Cell 88 1997 393 403
38. CA Milano PC Dolber HA Rockman Myocardial expression of a constitutively active alpha1B-adrenergic receptor in transgenic mice induces cardiac hypertrophy Proc Natl Acad Sci U S A 91 1994 10109 10113
39. SB Liggett LE Wagoner LL Craft The Ile 164 beta-2 adrenergic receptor polymorphism adversely affects the outcome of congestive heart failure J Clin Invest 102 1998 1534 1539
40. HH Vincent Ma in’t Veld AJ, Boomsma F, et al. Compound ICI 118,551, a beta-2 adrenoceptor antagonist, lowers blood pressure J Hypertens S3 1985 S247 S249
41. T Kurz D Richardt S Adler Presynaptic effects of carvedilol in the human heart [abstract] Circulation 102 2000 II629
42. J Lindenfeld BD Lowes MR Bristow Hypotension with dobutamine: β-adrenergic antagonist selectivity at low doses of carvedilol Ann Pharmacother 33 1999 1266 1269
43. MR Bristow WT Abraham EM Gilbert Relationships between carvedilol stereoisomer plasma concentration and beta receptor occupancies in subjects with chronic heart failure in the Multicenter Oral Carvedilol Heart Failure Assessment (MOCHA) [abstract] Eur Heart J 17 1996 135A
44. M. Guillen Curiosity killed the lights Five equations that changed the world 1995 Hyperion New York
45. W. Dunham Bernoulli trials The mathematical universe: an alphabetical journey through the great proofs, problems, and personalities 1994 John Wiley New York
46. H Krum Beta-blockers in heart failure: the ‘new wave’ of clinical trials Drugs 58 1999 203 210
47. RM Oren HO Ventura I Pina Prevalence of beta blocker use in heart failure clinics: report from the UNITE-HF multicenter heart failure database [abstract] J Cardiac Failure 6 2000 2A 79A